Shreyam Acharya
@ShreyamA
Followers
205
Following
853
Media
88
Statuses
1K
DM Resident (Department of Hematology), MD (Laboratory Medicine), AIIMS, New Delhi
Joined June 2011
The public comment period is now open! We welcome your feedback on the proposed guidelines for evaluation of #MRD testing in B-ALL https://t.co/qTmljhe2df All stakeholders are encouraged to participate-- closes October 29th. #hematology #flowcytometry @ICCS_Education @AMPath
cap.org
Guideline to establish evidence-based standards and recommendations in the application, interpretation, and actionability of MRD for ALL (B-ALL and T-ALL,…
0
5
4
Put your knowledge of clinical hematology to the test with EHA's new CasEscape – Nutty's adventure! Join Nutty the squirrel on a summer ☀️ adventure in our latest EHA CasEscape – Nutty's Adventure! 🐿️🌰🌳 Solve a clinical case to uncover hidden treasures. Manage Rose, a
0
2
4
Congratulations to the legendary Bruce Greig, winner of the Wallace H. Coulter Award for his lifetime contributions to the science, education and practice of Clinical Cytometry! #FlowICCS25
0
5
10
Don’t report percentage of antigen expression, report quantitatively molecules/cell. Dr. Jean Oak tells you how, and illustrates how it is used for targeted therapy monitoring. #FlowICCS25
1
3
2
#FlowICCS2025 The course started with basic but core information about flow in hematology. Andrea N. Marcogliese discussed the utility of flow, B and T cell maturation, the lineage specific antigens, and components of flow. https://t.co/V1kQ20q6tL
https://t.co/mE5MbtR2Wa
0
0
1
The ICCS resources are available here https://t.co/FyVN7vKsyG
0
0
0
ICCS annual meeting started after two and half days of flow cytometry course. I will share the key points that were discussed these days and the literature supporting the opinions. Stay tuned. Also, feel free to check the free ICCS resources. They are awesome #FlowICCS2025
1
1
1
⭐️ AML Pathways of treatment AJH 2025 AML Update on Diagnosis and Management - Frontline and Relapse by @ShaiShimony
@MaxStahlMD
0
23
77
Acute erythroid leukemia or acute myeloid leukemia with mutated TP53? The battle of phenotype versus genotype | Blood | American Society of Hematology @XeniaParisi #hemepath #molpath
ashpublications.org
0
13
77
➡️ Check out our paper on Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms @Haematologica
https://t.co/5GbojW829A ✅ A clinically relevant and easy to use TP53 aberration burden stratification and a closer look at outcomes
11
38
125
Can’t make this shit up. For love of God/ mother and the child- don’t give anything except mother’s milk to the baby for the first 6 months. Not even water. Definitely not honey. Not Cows milk. Ps have seen sepsis/botulism/seizure and everything in between thanks to above
17
108
1K
What are the factors we should consider while interpreting a LN flow? It begins with https://t.co/mR5ZGN1X9z The equivalent effect of T cell rosetting of HRS, how to block it, how to purify it.
academic.oup.com
Abstract. We demonstrate the feasibility of using flow cytometry (FC) to identify the Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma
1
0
0
#FlowTCS2024
@CytometryIndia Apologizing for the late sharing. Day 2 started with an interesting lecture on IPT approach to CHL by Dr Brentwood.
1
0
0
Whether you can understand it or not, AI is going to help you in any modern science field. Hematology is not an exception. https://t.co/mmLKw376qa
0
0
0
Then we discussed the euroflow panels that were standardized with great efforts and were made open for everyone. Note: Euroflow has pre-analytical, analytical protocols, reference values of different populations, and even data analysis templates. https://t.co/UdRYToeesv
0
0
0